Browse the corpus

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to manage various conditions, including inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis. This drug is available over-the-counter and in prescription strength. This activity reviews ibuprofen's mechanism of action, adverse event profiles, dosing considerations, pharmacokinetics, contraindications, box warnings, and monitoring protocols, which are critical areas of focus. Understanding ibuprofen's pharmacology enables healthcare professionals to optimize dosage regimens and minimize potential adverse effects. This educational activity also discusses the role of the interprofessional healthcare team in providing quality patient care using ibuprofen therapy, improving patient outcomes. Objectives: Identify the clinical indications for ibuprofen therapy. Evaluate the potential adverse reactions associated with ibuprofen administration. Implement effective monitoring strategies for patients receiving ibuprofen therapy. Implement effective collaboration and communication between interprofessional team members to improve care for patients who might benefit from ibuprofen therapy. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Ibuprofen's toxic potential is derived from its inhibition of the cyclooxygenase pathway and the subsequent effects on various cellular processes and multiple organ systems. Prostaglandins and thromboxanes help maintain the gastric mucosal layer and renal blood flow; ibuprofen is associated with a mildly elevated risk of adverse gastrointestinal and renal events, even at therapeutic levels. Ibuprofen is the most common NSAID involved in overdose cases; 29% of overdoses are the result of ibuprofen ingestion alone. Patients can also overdose by ingesting ibuprofen combined with other analgesics.[72] One study created a risk score for improving the risk-benefit ratio of NSAID administration; this score was accurate in categorizing the one-year risk of significant toxicity among NSAID users.[73] Reye syndrome is an increasingly rare presentation, primarily due to international efforts to curb aspirin usage since the 1980s. Restricted aspirin administration to children in the United Kingdom reduced the incidence of Reye syndrome from 100 cases in 1984 to 3 cases in 2000.[71] NSAIDs damage the mitochondria in hepatocytes, precipitating Reye syndrome.[74] Furthermore, the mechanism of NSAID-induced liver damage remains largely unknown. Due to the increasing use of ibuprofen in children, the possibility of increased rates of drug-induced liver damage and Reye syndrome should be considered.[71] The maximum recommended daily dose of ibuprofen is 3200 mg. Overdosing on ibuprofen can cause severe toxicity, particularly in children ingesting 400 mg/kg or more. Complications of overdose include seizures, apnea, hypertension, and potential renal and hepatic dysfunction. Chronic administration of high-dose ibuprofen is also associated with increased risks of myocardial infarction.[42] Management of Overdose

The maximum recommended daily dose of ibuprofen is 3200 mg. Overdosing on ibuprofen can cause severe toxicity, particularly in children ingesting 400 mg/kg or more. Complications of overdose include seizures, apnea, hypertension, and potential renal and hepatic dysfunction. Chronic administration of high-dose ibuprofen is also associated with increased risks of myocardial infarction.[42] Management of Overdose There is no available antidote for ibuprofen. The toxicity resolves with time and supportive care. The management of severe ibuprofen toxicity typically involves supportive care and interventions like continuous renal replacement therapy (CRRT) or hemodialysis (HD). Despite ibuprofen's large molecule size and high protein binding, which typically limits dialysis clearance, CRRT can stabilize metabolic balance and support hemodynamics. In patients with significant metabolic acidosis and hemodynamic instability, CRRT may be initiated to facilitate the gradual elimination of ibuprofen and restore homeostasis, even though it does not acutely remove the drug.[75] Selective Plasma Adsorption (SPAD) has demonstrated potential as a treatment for severe ibuprofen overdose. This process uses albumin dialysate to eliminate highly protein-bound toxins, improving outcomes for patients with multi-organ failure and shock.[76]

Successful medication-based treatment requires updated clinical knowledge, a thorough understanding of the patient, and realistic treatment goals based on current evidence. The primary clinician, physicians, advanced practice providers (eg, NPs PAs), nursing staff, and pharmacists collaborate to ensure the highest quality of patient care involving ibuprofen therapy by adhering to the following principles: Providers should only prescribe ibuprofen for the recommended FDA-approved or off-label indications while considering contraindications or factors that increase the risk of adverse effects. Any patient-reported ibuprofen use should be documented, including the frequency and dosage. Nursing staff may obtain and report this information to the attending physician. Any patient with suspected gastritis, ulceration, anemia, or thrombocytopenia should be asked about ibuprofen use. Ibuprofen toxicity should be considered when assessing patients who have overdosed on an unknown substance. Ibuprofen may be administered for primary diagnosis or mild to moderate symptomatic control in patients experiencing pain.[28][22][14][15][5] NSAIDs such as ibuprofen have demonstrated potential as anticancer agents and should be considered as components of cancer treatment regimens when appropriate and supported by recent research. Aspirin and other NSAIDs are recommended for colorectal cancer and cardiovascular disease prevention. Appropriate monitoring of pain levels, new GI complaints, blood pressure, and renal function reduces the risk of adverse effects associated with NSAID therapy. Nursing staff can contribute significantly to this effort.[57][61] Alternating acetaminophen and ibuprofen doses for pediatric patients can reduce refractory fever more effectively than ibuprofen monotherapy.[10] Ibuprofen and indomethacin are equally effective for closing a PDA in neonatal patients. However, ibuprofen is associated with reduced rates of nephrotoxicity and systemic vasoconstriction.[6] Pediatric/neonatal specialty nurses and pharmacists should collaborate to ensure safe administration to these patients. Intravenous ibuprofen is compatible with some total parenteral nutrition formulations. These combinations can be administered simultaneously to neonates with PDA.[40] Ibuprofen or aspirin should be administered with colchicine to relieve acute pericarditis and reduce recurrent pericarditis.[19]

Ibuprofen and indomethacin are equally effective for closing a PDA in neonatal patients. However, ibuprofen is associated with reduced rates of nephrotoxicity and systemic vasoconstriction.[6] Pediatric/neonatal specialty nurses and pharmacists should collaborate to ensure safe administration to these patients. Intravenous ibuprofen is compatible with some total parenteral nutrition formulations. These combinations can be administered simultaneously to neonates with PDA.[40] Ibuprofen or aspirin should be administered with colchicine to relieve acute pericarditis and reduce recurrent pericarditis.[19] Awareness of these evidence-based principles can improve monitoring and outcomes for patients who may benefit from ibuprofen therapy. An interprofessional team approach and communication among clinicians (MDs, DOs, NPs, PAs), pharmacists, and nurses are crucial to preventing adverse reactions and improving outcomes for patients receiving ibuprofen.